SOPHiA GENETICS (SOPH) Gains from Investment Securities (2022 - 2026)
SOPHiA GENETICS's (SOPH) quarterly Gains from Investment Securities came in at $1.9 million in Q2 2026, down 38.05% year-over-year from $3.1 million in Q2 2025, and up 35.2% quarter-over-quarter from $1.4 million in Q1 2026.
Powered by 
Analysis
SOPHiA GENETICS (SOPH) Gains from Investment Securities (2022 - 2026) Analysis & Trends
SOPHiA GENETICS has disclosed Gains from Investment Securities across 4 years of filings, most recently posting $1.9 million for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 44.53 Bn | 37.29 Bn | 695.95 Mn |
| 2 | Waystar Holding | 4.81 Bn | 4.62 Bn | 221.99 Mn |
| 3 | Doximity | 4.74 Bn | 4.05 Bn | 132.93 Mn |
| 4 | CCC Intelligent Solutions Holdings | 4.41 Bn | 4.30 Bn | 210.64 Mn |
| 5 | EverCommerce | 1.40 Bn | 1.27 Bn | 119.50 Mn |
| 6 | Schrodinger | 1.32 Bn | 904.47 Mn | 32.43 Mn |
| 7 | Certara | 1.21 Bn | 1.03 Bn | 58.15 Mn |
| 8 | GoodRx Holdings | 1.18 Bn | 887.53 Mn | 179.41 Mn |
| 9 | Healthstream | 853.81 Mn | 787.08 Mn | 54.72 Mn |
| 10 | SOPHiA GENETICS | 554.05 Mn | 446.39 Mn | 15.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.93 Mn |
| Mar 31, 2026 | 1.43 Mn |
| Jun 30, 2025 | 3.11 Mn |
| Mar 31, 2025 | 925,000.00 |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 169,000.00 |
| Jun 30, 2022 | 53,000.00 |
| Mar 31, 2022 | 166,000.00 |